Journals / Haseki Tıp Bülteni / 2019 / Cilt: 57 - Sayı: 2

Relation of Apathy to Motor and Non-motor Findings in Parkinson’s Disease

Parkinson Hastalığında Apatinin Motor ve Non-motor Bulgularla İlişkisi

Pages
129–134
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study showed that apathy, one of the non-motor symptoms, was more prominent in male gender, associated with UPDRS scores, clinical stage and bradykinesia, and accompanied by depression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: It has been shown that motor symptoms, as well as nonmotor symptoms, significantly affect the quality of life of patients with idiopathic Parkinson’s disease.
📊
Key Findings & Data:Methods: Patients with stage 1-3 IPH according to the Hoehn-Yahr Scale (H&Y) were included in the study.
💡
Conclusion & Impact:Conclusion: Our study showed that apathy, one of the non-motor symptoms, was more prominent in male gender, associated with UPDRS scores, clinical stage and bradykinesia, and accompanied by depression.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: It has been shown that motor symptoms, as well as nonmotor symptoms, significantly affect the quality of life of patients with idiopathic Parkinson’s disease. In our study, the association of apathy, one of the NMS, with motor and non-motor symptoms was investigated. Methods: Patients with stage 1-3 IPH according to the Hoehn-Yahr Scale (H&Y) were included in the study. Patients who received dementia diagnosis according to the DSM IV criteria were excluded from the study. The patients were evaluated using the Unified Parkinson’s Disease Rating Scale (UPDRS), non-motor symptoms Questionnaire (NMSQ), Geriatric Depression Scale (GDS), and the revised diagnostic criteria for apathy. Results: Apathy was found in 26 of 68 patients who were included in the study. Patients with and without apathy were compared in terms of age, clinical and demographic characteristics, L-dopa equivalent doses, depression, and NMSQ scores. The group of patients with apathy consisted of nine females and 17 males and the mean age was 64.3±7.7 years. The non-apathy group included 25 females and 17 males and the mean age was 66.8±9.1 years. There was no statistically significant difference between the groups in terms of age, education, age at onset, duration of illness and L-dopa equivalent doses. The maleto-female ratio was significantly higher in the apathy group. The mean GDS and NMSQ scores in the apathy group were significantly higher than in the non-apathy group. There was a statistically significant difference between the groups in H&Y stage and total UPDRS and subscales scores. It was noteworthy that the rate of stage 3 patients was higher in the group of patients with apathy. The number of patients having bradykinesia in the apathy group and the number of patients having tremor in the group without apathy was higher. Conclusion: Our study showed that apathy, one of the non-motor symptoms, was more prominent in male gender, associated with UPDRS scores, clinical stage and bradykinesia, and accompanied by depression.

Özet

Amaç: İdiyopatik Parkinson hastalığında (İPH) motor semptomlar kadar non-motor semptomların (NMS) da yaşam kalitesini önemli ölçüde etkilediği belirlenmiştir. Çalışmamızda, NMS’lerden biri olan “apati”nin motor ve NMS’lerle ilişkisi araştırılmıştır. Yöntemler: Çalışmaya, İPH tanısı alan, Hoehn-Yahr Skalasına (H&Y) göre evre 1-3 arası olan hastalar dahil edildi. DSM-IV kriterlerine göre demans tanısı alan hastalar çalışma dışı bırakıldı. Hastalar, Bileşik Parkinson Hastalığı Değerlendirme Ölçeği (BPHDÖ), Non-motor Belirtiler Anketi (NMSQ), Geriatrik Depresyon Ölçeği (GDÖ), Modifiye Apati Klinik Tanı Kriterleri uygulanılarak değerlendirildi. Bulgular: Çalışmaya alınan 68 hastanın 26’sında apati varken 42’sinde apati saptanmadı. Her iki grup yaş, klinik, demografik özellikler, aldıkları eşdeğer L-Dopa dozları, depresyon ve NMS test puanları açısından birbiri ile karşılaştırıldı. Apatisi olan grubun dokuzu kadın, 17’si erkekti ve yaş ortalamaları 64,3±7,7 yıl idi. Apatisi olmayan grup 25 kadın, 17 erkek hastadan oluşmaktaydı ve yaş ortalamaları 66,8±9,1 yıl olarak saptandı. Gruplar arasında yaş ortalaması, eğitim düzeyi, hastalık başlangıç yaşı, hastalık süresi ve eşdeğer L-Dopa dozları arasında istatistiksel olarak anlamlı fark saptanmadı. Apatisi olan grupta erkek cinsiyet oranı anlamlı yüksekti, bu grubun GDÖ ve NMSQ ortalamaları diğer gruba göre anlamlı yüksek saptandı. Grupların H&Y evre oranlarında ve BPHDÖ toplam puan ve alt ölçeklerinde apatisi olan grupta istatistiksel olarak anlamlı fark bulundu. Apatisi olan grubun evre 3 yüksekliği dikkati çekmiştir. Apatisi olan grubun bradikinezi oranı, olmayan grubun tremor oranı daha yüksek saptandı. Sonuç: Çalışmamızda, NMS’lerinden biri olan apatinin, erkek cinsiyette daha belirgin olduğu, BPHDÖ skorları, klinik evresi ve bradikinezi ile ilişkili olduğu ve depresyonun eşlik ettiği saptanmıştır.

🔖

Cite This Article

GÜRBÜZ, M. K., AKDAĞ, G., DÜZ, Ö. A., ÖZER, F., ÇOKAR, A. Ö., HANOĞLU, L. (2019). Relation of Apathy to Motor and Non-motor Findings in Parkinson’s Disease. Haseki Tıp Bülteni, Cilt: 57 - Sayı: 2, 129–134. https://ajindex.com/articles/192439

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry 2003;54:363-75.
  2. Rabinstein AA, Shulman LM. Management of behavioral and psychiatric problems in Parkinson’s disease. Parkinsonism Relat Disord 2000;7:41-50.
  3. Poewe W, Wenning G. The differential diagnosis of Parkinson’s disease. Eur J Neurol 2002;9:23-30.
  4. Dujardin K, Defebvre L. Apathy in Parkinson diseaseWhat are the underlying mechanisms? Neurology 2012;79:1082-83.
  5. Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord 2009;24:2175-86.
  6. Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson’s disease. Mov Disord 2007;22:778-84.
  7. Kirsch-Darrow L, Marsiske M, Okun MS, Bauer R, Bowers D. Apathy and depression: separate factors in Parkinson’s disease. J Int Neuropsychol Soc 2011;17:1058-66.
  8. Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale: a new instrument for detecting and quanrifying apathy: validation in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2006;77:579-84.
  9. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-42.
  10. Lang AET, Fahn S. Assessment of Parkinson’s disease. In MunsatTLed. Quantification of Neurologic Deficit. Stoneham: Butterworths, 1989.
  11. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1992 Spring;4:134-9. Marin RS. Apathy: a neuropsychiatric syndrome. Journal of Neuropsychiatry and Clinical Neuroscience 1991;3:243- 54. Chaudhuri KR, Martinez_Martin P, Schapira AHV, et al. International multicentre pilot study of the first comprehensive self-completed non motor symptoms questionnaire for Parkinson’s disease: The NMSQuest study. Mov Disorders. 2006;21:916-23.
  12. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale:a preliminary report. J Psychiatr Res 1982-1983;17:37-49. Dr. Turan Ertan. Geriatrik Depresyon Ölçeği ile Kendini Değerlendirme Depresyon Ölçeği’nin 60 yaş üzeri Türk populasyonunda geçerlilik ve güvenilirliği. Uzmanlık Tezi İ.Ü. Cerrahpaşa Tıp Fakültesi Psikiyatri Anabilim dalı İstanbul 1996.
  13. Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize Mini Mental Test’in Türk Toplumunda Hafif Demans Tanısında Geçerlilik ve Güvenilirliği. Türk Psikiyatri Dergisi 2002;13:273